Remove tag stanford-university
article thumbnail

‘Click’ chemistry used to tag proteins made by cancer cells 

Drug Discovery World

The new method involves adding chemical tags to sugar molecules which are added to cells. When the cells make these proteins, they remain marked with the chemical tag, meaning that researchers can identify them. . One of the prize recipients, Carbolyn Bertozzi from Stanford University, is a co-author of this study.

Protein 52
article thumbnail

Grand Rounds Ethics and Regulatory Series December 9, 2022: The Stepped Wedge Cluster Randomized Trial: Friend or Foe? (Monica Taljaard, PhD; David Magnus, PhD)

Rethinking Clinical Trials

University of Ottawa. Director, Stanford Center for Biomedical Ethics. Ottawa Hospital Research Institute. Full Professor, Epidemiology and Community Medicine. David Magnus, PhD. Raffin Professor of Medicine and Biomedical Ethics and Professor of Pediatrics, Medicine, and by courtesy of Bioengineering. Associate Dean for Research.

Trials 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Targeting a human protein may stop Ebola virus in its tracks

The Pharma Data

and University of Texas Medical Branch (UTMB) Professor Alexander Bukreyev, Ph.D. ” These insights were made possible thanks to an enzyme, called split-TurboID, which is a biotin ligase engineered by the lab of Stanford University Professor Alice Ting, Ph.D. The problems with Ebola polymerase.

Protein 52
article thumbnail

Beam makes USD 120M bet; GRAIL and Quest announce the collaboration; Brain organoids mimic infant’s brains; Improvement in T cells to kill cancer

Delveinsight

A new study from UCLA and Stanford University researchers observes that three-dimensional human stem cell-derived brain organoids can mature in a strikingly similar way to human brain development. Brain organoids grown in the lab mimic infant’s brains.

DNA 52
article thumbnail

Grand Rounds July 29, 2022: Effect of Early Treatment With Single-Dose Pegylated Interferon Lambda Among Patients With COVID-19: Results From The TOGETHER Trial (Edward Mills, PhD, FRCP; Jeffrey S. Glenn, MD, PhD)

Rethinking Clinical Trials

McMaster University, Canada. Stanford University. Edward Mills, PhD, FRCP. Department of Health Research Methods, Evidence & Impact. Glenn, MD, PhD. Grant Professor and Professor of Microbiology and Immunology. TOGETHER, COVID-19, Peginterferon Lambda. Key Points. Learn more about TOGETHER. pctGR, @Collaboratory1.

Trials 130
article thumbnail

AI is critical to solving new complexities in drug discovery

Drug Discovery World

It also carries a much higher price tag for failure. Radin created the company’s first drug development algorithms as part of his studies in biomedical informatics at Stanford University in 2014. On top of that, pharmaceutical development is extremely complex in itself.

Drugs 52